- Home
- MXCT vs XTNT Comparison
MXCT vs XTNT Comparison
Compare MXCT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MXCT | XTNT |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.5M | 86.2M |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MXCT | XTNT |
|---|---|---|
| Price | $0.77 | $0.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $7.50 | $1.50 |
| AVG Volume (30 Days) | ★ 1.3M | 130.2K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | $38,627,000.00 | ★ $53,337,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | $9.64 | N/A |
| P/E Ratio | ★ N/A | $21.53 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.34 |
| 52 Week High | $3.49 | $0.95 |
Technical Indicators
Market Signals| Indicator | MXCT | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 47.09 |
| Support Level | $0.75 | $0.55 |
| Resistance Level | $1.79 | $0.68 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 56.13 | 35.20 |
Price Performance
Historical ComparisonAbout MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.